CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 4 Open-market sale Director sold 3,082 shares at $54.15 ($166,884)
- 4 Open-market sale Director sold 5,153 shares at $60.00 ($309,180)
- 4 Open-market sale Director sold 1,509 shares at $56.12 ($84,692)
- 4 Shares withheld for taxes EVP, Corp Dev, GC & Secretary gave up 1,287 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 1,376 shares at $43.39 ($59,702)
- 4 Grant or award Director acquired 5,736 shares (grant or award)
- 4 Grant or award Director acquired 5,736 shares (grant or award)
- 4 Grant or award Director acquired 5,736 shares (grant or award)
- 4 Grant or award Director acquired 5,736 shares (grant or award)
- 4 Grant or award Director acquired 5,736 shares (grant or award)
- 4 Grant or award Director acquired 5,736 shares (grant or award)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 759 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief HR Officer gave up 237 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 95 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 7,893 shares (option exercise)
- 4 Grant or award Director acquired 7,569 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, Business Operations sold 2,430 shares at $56.93 ($138,340)
- 4 Open-market sale EVP, Business Operations sold 3,043 shares at an average $58.11 ($176,819)
Page 17 of 49 · 970 filings